30 participants
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2024-08-26
- Completion:
- 2028-03-31
Conditions
- NSCLC Patients With EGFR Activating Mutation
- Adenoid Cystic Carcinoma Metastatic
- Adenoid Cystic Carcinoma of the Head and Neck
Interventions
- DRUG
No Results Yet